United Kingdom (UK) Cell And Gene Therapy Manufacturing Market (2025-2031) | Competitive Landscape, Share, Growth, Analysis, Segmentation, Trends, Size & Revenue, Outlook, Value, Companies, Industry, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market - Industry Life Cycle

3.4 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market - Porter's Five Forces

3.5 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.6 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Scale, 2021 & 2031F

3.7 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Mode, 2021 & 2031F

3.8 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Workflow, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investment in research and development in cell and gene therapy technologies in the UK.

4.2.2 Favorable regulatory environment supporting cell and gene therapy manufacturing.

4.2.3 Growing demand for personalized medicine driving the adoption of cell and gene therapy manufacturing in the UK.

4.3 Market Restraints

4.3.1 High initial investment and operational costs associated with setting up cell and gene therapy manufacturing facilities.

4.3.2 Limited scalability of current manufacturing processes for cell and gene therapies in the UK.

4.3.3 Challenges in achieving consistent quality and scalability in cell and gene therapy manufacturing.

6.1 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market, By Therapy Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Therapy Type, 2021- 2031F

6.1.3 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell therapy manufacturing, 2021- 2031F

6.1.4 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Gene therapy manufacturing, 2021- 2031F

6.2 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market, By Scale

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Pre-commercial/R&D scale manufacturing, 2021- 2031F

6.2.3 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Commercial scale manufacturing, 2021- 2031F

6.3 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market, By Mode

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Contract manufacturing, 2021- 2031F

6.3.3 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By In-house manufacturing, 2021- 2031F

6.4 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell processing, 2021- 2031F

6.4.3 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell banking, 2021- 2031F

6.4.4 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Process development, 2021- 2031F

6.4.5 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Fill & finish operations, 2021- 2031F

6.4.6 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Analytical and quality testing, 2021- 2031F

6.4.7 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Raw material testing, 2021- 2031F

6.4.8 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F

6.4.9 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Export to Major Countries

7.2 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Imports from Major Countries

8.1 Number of collaborations between academia and industry in cell and gene therapy manufacturing research.

8.2 Percentage increase in the number of approved cell and gene therapy products in the UK market.

8.3 Adoption rate of advanced manufacturing technologies in cell and gene therapy production in the UK.

8.4 Average time to market for new cell and gene therapy products in the UK.

8.5 Rate of successful technology transfer from research to commercial manufacturing in the UK.

9.1 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.2 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Scale, 2021 & 2031F

9.3 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Mode, 2021 & 2031F

9.4 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Workflow, 2021 & 2031F

10.1 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Cell And Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters